Grufity logoGrufity logo
ScreenerStocksFundsSectorsWatchlists
NEOG

Neogen Corp

NEOG

18.18USD-0.17 (-0.93%)Market Closed
Watchlist

Market Summary

USD18.18-0.17
Market Closed
-0.93%

NEOG Alerts

  • 1 major insider buys recently.
  • Big jump in Revenue (Y/Y)
  • Big fall in earnings (Y/Y)

NEOG Stock Price

View Fullscreen

NEOG RSI Chart

NEOG Valuation

Market Cap

3.9B

Price/Earnings (Trailing)

-147.97

Price/Sales (Trailing)

4.28

EV/EBITDA

29.57

Price/Free Cashflow

50.3

NEOG Price/Sales (Trailing)

NEOG Profitability

EBT Margin

-1.50%

Return on Equity

-0.43%

Return on Assets

-0.3%

Free Cashflow Yield

1.99%

NEOG Fundamentals

NEOG Revenue

Revenue (TTM)

919.1M

Revenue Y/Y

73.02%

Revenue Q/Q

-5.3%

NEOG Earnings

Earnings (TTM)

-26.6M

Earnings Y/Y

-71.15%

Earnings Q/Q

-73.03%

Price Action

Last 7 days

4.2%

Last 30 days

17.2%

Last 90 days

-6.8%

Trailing 12 Months

17.1%

How does NEOG drawdown profile look like?

NEOG Financial Health

Current Ratio

5.18

NEOG Investor Care

Shares Dilution (1Y)

100.59%

Diluted EPS (TTM)

-0.13

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023720.7M822.4M919.1M0
2022514.5M527.2M531.2M630.7M
2021450.1M468.5M487.4M503.0M
2020418.9M418.2M426.1M433.3M
2019412.5M414.2M416.0M416.7M
2018388.7M397.9M403.3M409.7M
2017352.8M361.6M372.2M382.1M
2016309.8M321.3M330.1M341.2M
2015271.7M283.1M290.3M301.5M
2014236.2M247.4M256.5M265.3M
2013200.1M207.5M216.3M225.2M
2012179.1M184.0M188.1M193.9M
2011164.6M172.7M175.5M176.4M
20100140.5M148.6M156.6M

Latest Insider Trading transactions for NEOG

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Nov 03, 2023
boehm william t
bought
32,110
16.055
2,000
-
Oct 25, 2023
jones douglas edward
bought
151,727
15.1727
10,000
chief operating officer
Oct 13, 2023
lilly jason warren
sold
-5,300
15.1
-351
vice president
Oct 12, 2023
tobin james p
bought
45,567
15.189
3,000
-
Oct 11, 2023
lilly jason warren
sold
-30,087
15.6949
-1,917
vice president
Oct 11, 2023
boehm william t
sold
-40,455
15.614
-2,591
-
Oct 11, 2023
naemura david h.
bought
150,333
15.0333
10,000
cfo
Aug 18, 2023
boehm william t
sold
-33,890
22.5939
-1,500
-
Aug 18, 2023
boehm william t
acquired
23,430
15.62
1,500
-
Apr 25, 2023
jones douglas edward
sold (taxes)
-4,950
16.67
-297
chief operating officer

1–10 of 50

Which funds bought or sold NEOG recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Dec 06, 2023
CITIGROUP INC
reduced
-3.69
-428,513
1,964,680
-%
Nov 30, 2023
Neo Ivy Capital Management
reduced
-72.96
-542,000
162,000
0.07%
Nov 27, 2023
BANQUE PICTET & CIE SA
unchanged
-
-7,793,080
45,010,500
0.53%
Nov 24, 2023
DEUTSCHE BANK AG\
added
19.45
35,920
2,011,520
-%
Nov 21, 2023
COMERICA BANK
added
917
12,356,800
12,451,800
0.06%
Nov 20, 2023
SILVER OAK SECURITIES, INCORPORATED
new
-
1,483
1,483
-%
Nov 17, 2023
SkyView Investment Advisors, LLC
unchanged
-
-22,000
130,000
0.05%
Nov 17, 2023
Diversified Trust Co
added
8.36
-41,823
505,863
0.02%
Nov 17, 2023
OLD NATIONAL BANCORP /IN/
reduced
-7.56
-63,822
237,219
0.01%
Nov 16, 2023
Creative Planning
added
0.38
-77,011
456,604
-%

1–10 of 44

Latest Funds Activity

Are funds buying NEOG calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own NEOG
No. of Funds

Schedule 13G FIlings of Neogen Corp

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
susquehanna securities, llc
3.8%
8,291,607
SC 13G/A
Feb 14, 2023
norges bank
8.52%
18,422,570
SC 13G/A
Feb 09, 2023
vanguard group inc
8.82%
19,057,576
SC 13G/A
Feb 08, 2023
wasatch advisors inc
-
0
SC 13G/A
Jan 23, 2023
blackrock inc.
11.3%
24,460,988
SC 13G/A
Sep 16, 2022
susquehanna securities, llc
5.4%
11,733,386
SC 13G
Sep 09, 2022
wasatch advisors inc
-
0
SC 13G/A
Sep 01, 2022
norges bank
5.79%
6,248,066
SC 13G
Feb 14, 2022
brown capital management llc
11.04%
11,899,239
SC 13G/A
Feb 11, 2022
wasatch advisors inc
-
0
SC 13G

Recent SEC filings of Neogen Corp

View All Filings
Date Filed Form Type Document
Nov 03, 2023
4
Insider Trading
Oct 31, 2023
4
Insider Trading
Oct 31, 2023
4
Insider Trading
Oct 31, 2023
4
Insider Trading
Oct 31, 2023
4
Insider Trading
Oct 31, 2023
4
Insider Trading
Oct 31, 2023
4
Insider Trading
Oct 31, 2023
4
Insider Trading
Oct 31, 2023
4
Insider Trading
Oct 31, 2023
4
Insider Trading

Peers (Alternatives to Neogen Corp)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
160.7B
29.6B
10.51% -19.98%
27.16
5.44
-5.39% -12.54%
44.1B
3.6B
24.23% 23.99%
53.65
12.3
7.43% 22.86%
37.3B
7.0B
16.28% -18.61%
32.89
5.33
5.03% -14.68%
15.2B
9.3B
1.84% -9.68%
19.95
1.64
-9.69% -38.22%
11.7B
2.4B
2.99% 40.82%
-41.48
4.86
19.99% 60.62%
MID-CAP
10.5B
4.2B
16.20% -2.67%
22.08
2.49
11.49% 8.84%
8.7B
1.8B
2.84% 34.94%
31.81
4.88
29.62% 20.49%
6.9B
988.7M
40.66% 50.03%
-13.86
7
27.41% 8.51%
3.9B
919.1M
17.21% 17.06%
-147.97
4.28
73.02% -172.93%
3.0B
535.8M
8.75% -45.64%
-7.02
5.66
24.38% 26.34%
SMALL-CAP
531.2M
297.1M
54.98% -22.82%
-5.87
1.79
-6.74% -21.60%
71.5M
21.4M
-81.47% -93.49%
-0.62
3.34
-8.80% -39.66%
31.2M
9.2M
-11.33% -33.68%
-1.76
3.4
16.43% 48.38%
12.0M
13.4M
-4.35% -39.31%
-1.21
0.9
-26.43% -20.54%
120.4K
-
-82.76% -93.43%
0
0.76
-57.78% -93.13%

Neogen Corp News

Latest updates
SETE News07 Dec 202306:40 pm34 hours ago
Yahoo Finance26 Oct 202307:00 am43 days ago
Yahoo Finance17 Oct 202307:00 am52 days ago
Nasdaq10 Oct 202307:00 am59 days ago
Yahoo Finance04 Sep 202307:00 am3 months ago
GuruFocus.com30 Aug 202307:00 am3 months ago
Seeking Alpha30 Aug 202207:00 am15 months ago
Greater Wilmington Business Journal26 Jul 202207:00 am16 months ago
Spokane Journal of Business13 Jan 202208:00 am23 months ago
ThinkMarkets15 Jun 202104:37 pm2 years ago
TMS Brokers13 May 202104:04 pm2 years ago
TMS Brokers16 Nov 201904:39 pm4 years ago
Thomasnet26 Mar 201907:00 am4 years ago
InvestorIdeas.com30 Aug 201806:22 pm5 years ago
InvestorIdeas.com30 Aug 201806:22 pm5 years ago

Financials for Neogen Corp

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue-5.3%22924221823013214012813112812711711510910910010810111098.00107100
Gross Profit-5.2%11712310811362.0065.0057.0061.0060.0058.0054.0053.0050.0052.0045.0051.0048.0051.0045.0050.0047.00
Operating Expenses-2.1%98.0010092.0012056.0047.0051.0048.0038.0037.0038.0034.0031.0032.0032.0033.0032.0032.0030.0032.0030.00
  S&GA Expenses6.7%46.0043.0039.0036.0023.0021.0021.0021.0021.0021.0019.0018.0017.0016.0018.0018.0018.0018.0017.0018.0017.00
  R&D Expenses-4.7%7.007.007.007.005.004.005.004.004.004.004.004.004.003.004.004.004.004.003.003.003.00
EBITDA Margin---0.08*0.07*0.13*0.16*0.17*0.19*0.20*0.21*0.21*0.22*0.22*0.22*0.21*0.22*0.22*0.22*0.22*0.22*0.23*
Income Taxes-92.5%0.002.00-10.508.001.004.001.002.005.004.003.003.004.005.002.003.003.004.004.004.002.00
Earnings Before Taxes-78.3%2.008.00-2.26-34.097.0019.007.0013.0022.0020.0016.0019.0020.0021.0014.0019.0018.0019.0017.0020.0017.00
EBT Margin----0.01*0.00*0.08*0.11*0.12*0.14*0.16*0.16*0.17*0.17*0.17*0.17*0.17*0.18*0.18*0.18*0.18*0.18*0.18*
Net Income-73.0%2.006.008.00-41.845.0015.005.0011.0017.0016.0013.0016.0016.0016.0012.0016.0015.0016.0013.0016.0015.00
Net Income Margin----0.02*-0.03*0.07*0.09*0.10*0.11*0.13*0.13*0.14*0.14*0.14*0.14*0.14*0.14*0.14*0.15*0.15*0.16*0.17*
Free Cashflow----17.07-18.73-14.1420.007.0018.0023.0022.0012.0022.0025.0026.0020.0017.0024.0021.0010.0017.0016.00
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets0.1%4,5614,5544,5614,563977993981968932920880846822797774751721696673660641
  Current Assets-0.4%584586555643608627610611609591555578557537515500474450423414396
    Cash Equivalents9.6%17916367.0010010744.0043.0051.0071.0076.0073.0011461.0066.0051.0066.0056.0042.0094.0010297.00
  Inventory5.1%14113414413612912211310710210199.0093.0098.0095.0089.0086.0088.0086.0085.0079.0079.00
  Net PPE11.2%22119916514812111110510110010098.0084.0081.0079.0078.0077.0075.0075.0076.0074.0073.00
  Goodwill0.0%2,1382,1372,1352,1221,975143150143130131133112112110110104103104104103103
Liabilities-0.4%1,4151,4201,3831,45794.0010610610177.0080.0073.0068.0070.0072.0062.0060.0061.0058.0053.0058.0059.00
  Current Liabilities-5.0%13814510715367.0078.0066.0063.0051.0054.0046.0045.0046.0048.0039.0039.0040.0038.0034.0039.0039.00
    LT Debt, Non Current0.1%886885885924-----------------
Shareholder's Equity0.4%3,1463,1343,1263,106884887876865855840808777752725712691660638620602582
  Retained Earnings0.3%567565559551593588573568557540524510495479462450434419403390374
  Additional Paid-In Capital0.1%2,5722,5682,5652,561313310308305298295290273264249255244232222217216212
Accumulated Depreciation-100.0%-120---105---98.00---75.00---66.00---
Shares Outstanding0.0%216216216216108108108108107107107106106106106105105104104104104
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations-74.7%23,00990,966-17,069-18,726-14,14320,3906,59117,84723,21021,96911,59622,39025,13425,62819,77816,75323,71920,87710,38216,50116,082
  Share Based Compensation-8.0%2,6382,8662,8122,6321,8672,1091,6071,7481,6901,6641,5811,5111,6811,6731,6401,6121,5431,4061,3061,4001,431
Cashflow From Investing-226.3%-8,6846,87619,52393,00281,638-17,099-15,386-39,337-25,407-31,710-60,91822,796-35,732-12,208-42,951-18,265-15,361-75,515-20,361-15,698-7,574
Cashflow From Financing321.4%1,062252-39,977-79,261905-1,0291,2235,5711,04810,74310,1437,5635,0951,4908,70210,5058,7083,2823491,2768,992

NEOG Income Statement

2023-08-31
Condensed Consolidated Statements of Income - USD ($)
$ in Thousands
3 Months Ended
Aug. 31, 2023
Aug. 31, 2022
Revenues  
Total revenue$ 228,987$ 132,349
Cost of Revenues  
Total Cost of Revenues112,22670,079
Gross Profit116,76162,270
Operating Expenses  
Sales and marketing45,78323,383
General and administrative45,12127,944
Research and development6,7224,881
Total Operating Expenses97,62656,208
Operating Income19,1356,062
Other (Expense) Income  
Interest income1,790971
Interest expense(18,456)(2)
Other expense(806)(372)
Total Other (Expense) Income(17,472)597
Income Before Taxes1,6636,659
Provision for Income Taxes1601,450
Net Income$ 1,503$ 5,209
Net Income Per Share  
Basic$ 0.01$ 0.05
Diluted$ 0.01$ 0.05
Weighted Average Shares Outstanding  
Basic216,309,084107,837,295
Diluted216,846,106107,857,477
Product Revenues  
Revenues  
Total revenue$ 204,401$ 106,792
Cost of Revenues  
Total Cost of Revenues96,95955,441
Service Revenues  
Revenues  
Total revenue24,58625,557
Cost of Revenues  
Total Cost of Revenues$ 15,267$ 14,638

NEOG Balance Sheet

2023-08-31
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Aug. 31, 2023
May 31, 2023
Current Assets  
Cash and cash equivalents$ 178,832$ 163,240
Marketable securities60,42482,329
Accounts receivable, net of allowance of $3,205 and $2,827137,669153,253
Inventories, net140,692133,812
Prepaid expenses and other current assets66,17653,297
Total Current Assets583,793585,931
Net Property and Equipment221,090198,749
Other Assets  
Right of use assets14,50511,933
Goodwill2,137,6022,137,496
Intangible assets, net1,588,0661,605,103
Other non-current assets16,04915,220
Total Assets4,561,1054,554,432
Current Liabilities  
Current portion of finance lease2,642 
Accounts payable90,21076,669
Accrued compensation14,86325,153
Income tax payable5,3996,951
Accrued interest3,43811,149
Deferred revenue3,7894,616
Other accruals17,78920,934
Total Current Liabilities138,130145,472
Deferred Income Tax Liability354,792353,427
Non-current debt886,177885,439
Other non-current liabilities35,83135,877
Total Liabilities1,414,9301,420,215
Commitments and Contingencies (note 12)
Equity  
Preferred stock, $1.00 par value, 100,000 shares authorized, none issued and outstanding00
Common stock, $0.16 par value, 315,000,000 shares authorized, 216,310,582 and 216,245,501 shares issued and outstanding at August 31, 2023 and May 31, 2023, respectively34,61034,599
Additional paid-in capital2,571,5172,567,828
Accumulated other comprehensive loss(26,496)(33,251)
Retained earnings566,544565,041
Total Stockholders' Equity3,146,1753,134,217
Total Liabilities and Stockholders' Equity$ 4,561,105$ 4,554,432
NEOG
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
 CEO
 WEBSITEwww.neogen.com
 EMPLOYEES2640

Neogen Corp Frequently Asked Questions


What is the ticker symbol for Neogen Corp? What does NEOG stand for in stocks?

NEOG is the stock ticker symbol of Neogen Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Neogen Corp (NEOG)?

As of Fri Dec 08 2023, market cap of Neogen Corp is 3.93 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NEOG stock?

You can check NEOG's fair value in chart. The fair value of Neogen Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Neogen Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NEOG so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Neogen Corp a good stock to buy?

The fair value guage provides a quick view whether NEOG is over valued or under valued. Whether Neogen Corp is cheap or expensive depends on the assumptions which impact Neogen Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NEOG.

What is Neogen Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 08 2023, NEOG's PE ratio (Price to Earnings) is -147.97 and Price to Sales (PS) ratio is 4.28. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NEOG PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Neogen Corp's stock?

In the past 10 years, Neogen Corp has provided -0.004 (multiply by 100 for percentage) rate of return.